nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.0363	0.0381	CbGpPWpGaD
Propranolol—ADRB3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0264	0.0277	CbGpPWpGaD
Propranolol—HTR1B—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.0239	0.025	CbGpPWpGaD
Propranolol—ADRB3—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0225	0.0236	CbGpPWpGaD
Propranolol—ADRB3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0218	0.0229	CbGpPWpGaD
Propranolol—ADRB3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0204	0.0213	CbGpPWpGaD
Propranolol—HTR1B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0197	0.0206	CbGpPWpGaD
Propranolol—Duloxetine—SLC6A3—Gilles de la Tourette syndrome	0.0191	0.417	CrCbGaD
Propranolol—ADRB3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0189	0.0198	CbGpPWpGaD
Propranolol—ADRB3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0184	0.0192	CbGpPWpGaD
Propranolol—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.0182	0.0191	CbGpPWpGaD
Propranolol—HTR1A—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.0182	0.0191	CbGpPWpGaD
Propranolol—ADRB3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0171	0.0179	CbGpPWpGaD
Propranolol—HTR1B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0168	0.0176	CbGpPWpGaD
Propranolol—HTR1B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0163	0.0171	CbGpPWpGaD
Propranolol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0157	0.0164	CbGpPWpGaD
Propranolol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0153	0.0161	CbGpPWpGaD
Propranolol—HTR1B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0152	0.0159	CbGpPWpGaD
Propranolol—HTR1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.015	0.0157	CbGpPWpGaD
Propranolol—ADRB3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0143	0.0149	CbGpPWpGaD
Propranolol—HTR1B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0141	0.0148	CbGpPWpGaD
Propranolol—HTR1B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0137	0.0143	CbGpPWpGaD
Propranolol—ADRB1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0134	0.014	CbGpPWpGaD
Propranolol—ADRB2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0131	0.0137	CbGpPWpGaD
Propranolol—ADRB1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.013	0.0136	CbGpPWpGaD
Propranolol—HTR1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0128	0.0134	CbGpPWpGaD
Propranolol—HTR1B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0128	0.0134	CbGpPWpGaD
Propranolol—ADRB2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0127	0.0133	CbGpPWpGaD
Propranolol—SLC22A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.0126	0.0132	CbGpPWpGaD
Propranolol—HTR1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0124	0.013	CbGpPWpGaD
Propranolol—ADRB1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0121	0.0127	CbGpPWpGaD
Propranolol—ADRB3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.012	0.0126	CbGpPWpGaD
Propranolol—ADRB2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0118	0.0124	CbGpPWpGaD
Propranolol—HTR1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0116	0.0121	CbGpPWpGaD
Propranolol—ADRB1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0112	0.0118	CbGpPWpGaD
Propranolol—Duloxetine—HTR2A—Gilles de la Tourette syndrome	0.011	0.24	CrCbGaD
Propranolol—ADRB2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.011	0.0115	CbGpPWpGaD
Propranolol—ADRB1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0109	0.0114	CbGpPWpGaD
Propranolol—HTR1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0107	0.0113	CbGpPWpGaD
Propranolol—ADRB2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0107	0.0112	CbGpPWpGaD
Propranolol—HTR1B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0106	0.0111	CbGpPWpGaD
Propranolol—HTR1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0104	0.0109	CbGpPWpGaD
Propranolol—ADRB1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0102	0.0106	CbGpPWpGaD
Propranolol—Atomoxetine—SLC6A3—Gilles de la Tourette syndrome	0.01	0.218	CrCbGaD
Propranolol—ADRB2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00993	0.0104	CbGpPWpGaD
Propranolol—HTR1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00971	0.0102	CbGpPWpGaD
Propranolol—HTR1B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00893	0.00936	CbGpPWpGaD
Propranolol—ADRB1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00846	0.00887	CbGpPWpGaD
Propranolol—ADRB2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00828	0.00867	CbGpPWpGaD
Propranolol—HTR1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00809	0.00848	CbGpPWpGaD
Propranolol—ADRB1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00711	0.00745	CbGpPWpGaD
Propranolol—ADRB2—Arf6 signaling events—MET—Gilles de la Tourette syndrome	0.00704	0.00738	CbGpPWpGaD
Propranolol—ADRB2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00696	0.00729	CbGpPWpGaD
Propranolol—HTR1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0068	0.00713	CbGpPWpGaD
Propranolol—ADRB2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0058	0.00608	CbGpPWpGaD
Propranolol—Atomoxetine—HTR2A—Gilles de la Tourette syndrome	0.00575	0.125	CrCbGaD
Propranolol—ADRB2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00563	0.00591	CbGpPWpGaD
Propranolol—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00494	0.00517	CbGpPWpGaD
Propranolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00434	0.00455	CbGpPWpGaD
Propranolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00422	0.00442	CbGpPWpGaD
Propranolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00393	0.00412	CbGpPWpGaD
Propranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00372	0.0039	CbGpPWpGaD
Propranolol—ADRB2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00368	0.00385	CbGpPWpGaD
Propranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00361	0.00379	CbGpPWpGaD
Propranolol—HTR1B—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00349	0.00366	CbGpPWpGaD
Propranolol—HTR1B—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00339	0.00355	CbGpPWpGaD
Propranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00337	0.00353	CbGpPWpGaD
Propranolol—HTR1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00324	0.00339	CbGpPWpGaD
Propranolol—HTR1B—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00315	0.00331	CbGpPWpGaD
Propranolol—HTR1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00314	0.00329	CbGpPWpGaD
Propranolol—HTR1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00293	0.00307	CbGpPWpGaD
Propranolol—ADRB3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00283	0.00297	CbGpPWpGaD
Propranolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00277	0.00291	CbGpPWpGaD
Propranolol—SLC22A2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00277	0.0029	CbGpPWpGaD
Propranolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00275	0.00288	CbGpPWpGaD
Propranolol—ADRB3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00275	0.00288	CbGpPWpGaD
Propranolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00269	0.00282	CbGpPWpGaD
Propranolol—HTR1A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00266	0.00278	CbGpPWpGaD
Propranolol—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00258	0.0027	CbGpPWpGaD
Propranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00258	0.0027	CbGpPWpGaD
Propranolol—ADRB3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00256	0.00269	CbGpPWpGaD
Propranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00252	0.00264	CbGpPWpGaD
Propranolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00251	0.00263	CbGpPWpGaD
Propranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0025	0.00262	CbGpPWpGaD
Propranolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00247	0.00258	CbGpPWpGaD
Propranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00245	0.00257	CbGpPWpGaD
Propranolol—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.0024	0.00252	CbGpPWpGaD
Propranolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00239	0.00251	CbGpPWpGaD
Propranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00236	0.00247	CbGpPWpGaD
Propranolol—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00234	0.00245	CbGpPWpGaD
Propranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00233	0.00244	CbGpPWpGaD
Propranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00228	0.00239	CbGpPWpGaD
Propranolol—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00224	0.00235	CbGpPWpGaD
Propranolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00223	0.00234	CbGpPWpGaD
Propranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00221	0.00231	CbGpPWpGaD
Propranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00216	0.00226	CbGpPWpGaD
Propranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00214	0.00225	CbGpPWpGaD
Propranolol—SLC22A2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00212	0.00222	CbGpPWpGaD
Propranolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00211	0.00221	CbGpPWpGaD
Propranolol—HTR1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00211	0.00221	CbGpPWpGaD
Propranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0021	0.0022	CbGpPWpGaD
Propranolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00205	0.00215	CbGpPWpGaD
Propranolol—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00205	0.00215	CbGpPWpGaD
Propranolol—HTR1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00205	0.00215	CbGpPWpGaD
Propranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.002	0.00209	CbGpPWpGaD
Propranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00195	0.00205	CbGpPWpGaD
Propranolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00191	0.002	CbGpPWpGaD
Propranolol—HTR1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00191	0.002	CbGpPWpGaD
Propranolol—ADRB3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00179	0.00188	CbGpPWpGaD
Propranolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00176	0.00184	CbGpPWpGaD
Propranolol—ADRB1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00168	0.00176	CbGpPWpGaD
Propranolol—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00165	0.00172	CbGpPWpGaD
Propranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00163	0.00171	CbGpPWpGaD
Propranolol—ADRB1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00163	0.00171	CbGpPWpGaD
Propranolol—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00161	0.00169	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.0016	0.00168	CbGpPWpGaD
Propranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0016	0.00167	CbGpPWpGaD
Propranolol—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0016	0.00167	CbGpPWpGaD
Propranolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00156	0.00164	CbGpPWpGaD
Propranolol—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00156	0.00164	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00155	0.00163	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—HDC—Gilles de la Tourette syndrome	0.00154	0.00161	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.00153	0.00161	CbGpPWpGaD
Propranolol—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00152	0.00159	CbGpPWpGaD
Propranolol—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00149	0.00156	CbGpPWpGaD
Propranolol—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00145	0.00152	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00145	0.00152	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00145	0.00152	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00141	0.00148	CbGpPWpGaD
Propranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.0014	0.00147	CbGpPWpGaD
Propranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00137	0.00143	CbGpPWpGaD
Propranolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00134	0.0014	CbGpPWpGaD
Propranolol—HTR1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00134	0.0014	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00132	0.00138	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00119	0.00125	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00116	0.00121	CbGpPWpGaD
Propranolol—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00114	0.00119	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—HDC—Gilles de la Tourette syndrome	0.00111	0.00116	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00108	0.00114	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00108	0.00113	CbGpPWpGaD
Propranolol—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00107	0.00112	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00105	0.0011	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00105	0.0011	CbGpPWpGaD
Propranolol—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00104	0.00109	CbGpPWpGaD
Propranolol—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00102	0.00107	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00101	0.00106	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00098	0.00103	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00095	0.000996	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00093	0.000974	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000923	0.000967	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000921	0.000965	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000909	0.000953	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000903	0.000946	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000883	0.000925	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000863	0.000905	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00086	0.000901	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000859	0.0009	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	0.000859	0.0009	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000844	0.000885	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000841	0.000881	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000838	0.000879	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000838	0.000878	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000834	0.000874	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000826	0.000865	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000822	0.000862	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00082	0.000859	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000801	0.00084	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.00079	0.000828	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000781	0.000818	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000777	0.000814	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000764	0.0008	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000756	0.000792	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000747	0.000782	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000686	0.000719	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000669	0.000701	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00064	0.000671	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000623	0.000653	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000621	0.000651	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000602	0.000631	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000589	0.000617	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000579	0.000607	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000576	0.000604	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000547	0.000573	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000544	0.00057	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000535	0.00056	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000523	0.000548	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000516	0.000541	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00051	0.000534	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000499	0.000523	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000495	0.000519	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000488	0.000511	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000484	0.000507	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000473	0.000496	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000461	0.000483	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000451	0.000473	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000441	0.000462	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000405	0.000425	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000323	0.000338	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000316	0.000331	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000309	0.000324	CbGpPWpGaD
